DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: API

Chemistry & Life Sciences

Understanding the Requirements of Safe HPAPI Manufacturing

11.09.2020 -

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

Chemistry & Life Sciences

The Impact of Covid-19 on the Pharmaceutical Industry

31.08.2020 -

Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...

Logistics & Supply Chain

The Risk of Dependency in Pharma Supply Chains

29.05.2020 - In recent decades, outsourcing of production steps, especially to Asia, has been one of the most important trends in manufacturing strategies in both the European and the US...

Reserach & Innovation

Biomade Peptides

09.09.2019 - Peptides make up around 8% of all active pharmaceutical ingredients (APIs). Those molecules are short polymers formed from the linking of ≤100 amino acids. They comprise some of...

News

Cerbios Expands HPAI Manufacturing Capacity

24.01.2019 - Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its...

News

Mallinckrodt to Split Into two Parts

12.12.2018 - Mallinckrodt Pharmaceuticals, the UK-domiciled, US-focused specialty drugmaker, plans to break up into two differentiated companies, with one focused on innovative specialty...

Plant Construction & Process Technology

Industry 4.0 Will Be a Game Changer for the Chemical Business

05.10.2018 - Global competition is pushing the industry towards faster time-to-market and more efficient and flexible processes. Modular plants are considered as potential bridges between the...

News

Lonza and Clovis Open New Monoplant for Ovarian Cancer Drug

04.10.2018 - Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.